Combining hypofractionated radiation therapy with immunotherapy for anorectal malignant melanoma: a case report

Wei-Jun Wang, Kuan-Der Lee, Wei-Yu Chen, J. Chiou, Long-Sheng Lu
{"title":"Combining hypofractionated radiation therapy with immunotherapy for anorectal malignant melanoma: a case report","authors":"Wei-Jun Wang, Kuan-Der Lee, Wei-Yu Chen, J. Chiou, Long-Sheng Lu","doi":"10.21037/TRO.2018.12.09","DOIUrl":null,"url":null,"abstract":"A 69-year-old man was diagnosed stage II anorectal malignant melanoma. He received radiotherapy which consisted of 25 Gy in 5 fractions to primary lesions and whole pelvis. He started pembrolizumab 3 weeks after the completion of radiotherapy. The treatment was complicated by CTCAE v4.0 grade 3 diarrhea. Ten weeks after radiotherapy, near total regression of the primary lesion as well as lymph nodes were found. The patient continued triweekly pembrolizumab and local recurrence was noted at 9 months after the initial diagnosis. Treating anorectal malignant melanoma with radiation assisted immunotherapy is worth considering and further study is warranted.","PeriodicalId":93236,"journal":{"name":"Therapeutic radiology and oncology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/TRO.2018.12.09","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic radiology and oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/TRO.2018.12.09","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

A 69-year-old man was diagnosed stage II anorectal malignant melanoma. He received radiotherapy which consisted of 25 Gy in 5 fractions to primary lesions and whole pelvis. He started pembrolizumab 3 weeks after the completion of radiotherapy. The treatment was complicated by CTCAE v4.0 grade 3 diarrhea. Ten weeks after radiotherapy, near total regression of the primary lesion as well as lymph nodes were found. The patient continued triweekly pembrolizumab and local recurrence was noted at 9 months after the initial diagnosis. Treating anorectal malignant melanoma with radiation assisted immunotherapy is worth considering and further study is warranted.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低分割放疗与免疫疗法联合治疗肛门直肠恶性黑色素瘤1例
一位69岁的男性被诊断为第二期肛门直肠恶性黑色素瘤。他接受了25 Gy的放射治疗,分5个部分对原发性病变和整个骨盆进行治疗。放疗结束3周后,他开始使用pembrolizumab。CTCAE v4.0 3级腹泻使治疗复杂化。放射治疗10周后,发现原发性病变和淋巴结几乎完全消退。患者继续每三周服用一次pembrolizumab,在初次诊断后9个月出现局部复发。放射辅助免疫治疗肛门直肠恶性黑色素瘤值得考虑,需要进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
0
期刊最新文献
A retrospective bilateral breast proton pencil beam scanning and photon volumetric arc therapy planning comparison. Analyses of treatment outcomes in advanced vulvar cancer: treated with postoperative radiotherapy or definitive radiotherapy/ chemoradiotherapy Prophylactic single fraction radiotherapy for the prevention of pathologic femoral fractures The impact of a mono-institutional experience in lung metastases treated with stereotactic body radiation therapy (SBRT): a retrospective analysis Editorial: Prophylactic single fraction radiotherapy for the prevention of pathologic femoral fractures
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1